Morgan Lewis Advises Iovance Biotherapeutics on New Laboratory and Office Facility

Morgan Lewis represented Iovance Biotherapeutics, a late-stage biotechnology company developing novel cancer immunotherapies, in negotiating a lease agreement to build an approximately 136,000 square foot commercial-scale facility in Philadelphia at the Navy Yard.

Partner Eric Stern led the Morgan Lewis team advising Iovance.

For more, read Iovance Biotherapeutics’s announcement.